A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes

NCT02846545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: Golimumab
BIOLOGICAL: Placebo

Sponsor

Janssen Research & Development, LLC